Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
3.900
-0.200 (-4.88%)
At close: Apr 28, 2026, 4:00 PM EDT
3.890
-0.010 (-0.26%)
After-hours: Apr 28, 2026, 7:33 PM EDT
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $228.23 million as of April 28, 2026. Its market cap has increased by 129.12% in one year.
Market Cap
228.23M
Enterprise Value
137.67M
1-Year Change
129.12%
Ranking
Category
Stock Price
$3.90
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $228.23M, an increase of 15.59%. That is a compound annual growth rate of 2.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Artiva Biotherapeutics | 255.08M |
| SAB Biotherapeutics | 247.37M |
| Sol-Gel Technologies | 244.62M |
| Arcturus Therapeutics Holdings | 244.15M |
| Adagene | 243.81M |
| Codexis | 238.08M |
| Fennec Pharmaceuticals | 235.81M |
| Nuvectis Pharma | 235.78M |